z-logo
Premium
Rapid and sensitive analysis of vincristine in human plasma using on‐line extraction combined with liquid chromatography/tandem mass spectrometry
Author(s) -
Corona Giuseppe,
Casetta Bruno,
Sandron Sara,
Vaccher Emanuela,
Toffoli Giuseppe
Publication year - 2008
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.3390
Subject(s) - chemistry , chromatography , protein precipitation , mass spectrometry , selected reaction monitoring , liquid chromatography–mass spectrometry , tandem mass spectrometry , extraction (chemistry) , atmospheric pressure chemical ionization , sample preparation , solid phase extraction , analytical chemistry (journal) , chemical ionization , ionization , ion , organic chemistry
A simple and rapid method has been developed and validated for the quantitation of vincristine in human plasma by liquid chromatography/tandem mass spectrometry (LC/MS/MS) with atmospheric pressure chemical ionization using on‐line solid‐phase extraction. The method uses vinblastine as internal standard and the sample preparation is limited just to a plasma protein precipitation step. Further sample clean‐up is carried out on‐line through a perfusion column preceding an analytical phenyl LC column, the latter directly connected to the mass spectrometer. Quantitation is performed in multiple reaction monitoring mode using the transitions of m/z 825.3 → 765.3 and 811.3 → 751.3 for vincristine and vinblastine respectively. The assay was linear (r 2 ≥0.99) in a concentration range from 0.1 to 500 ng/mL. Carry‐over, measured on the experimental set‐up, was less than 0.04%. Recovery for vincristine and the internal standard was within 90–95%. The intra‐day and inter‐day assay precision ranged from 1.2% to 6.8% RSD while mean percentage deviation from nominal value ranged from 0.01% to 6.1%. The proposed assay was found suitable for pharmacokinetics investigations and clinical therapeutic drug monitoring especially in pediatric cancer patients. Copyright © 2008 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom